TL;DR
This study identifies novel long non-coding RNAs (lncRNAs), termed LinfRNAs, that are significantly upregulated in human macrophages upon inflammatory stimulation (LPS). These LinfRNAs appear to be regulated by the NF-κB pathway and, in the case of hLinfRNA1, play a functional role in modulating the expression of key pro-inflammatory cytokines, suggesting they are important regulators of the inflammatory response.
What Problem Does This Paper Address?
Inflammation is a critical biological process, but its dysregulation contributes to numerous severe human diseases. While proteins and genomic factors are well-studied regulators of inflammation and macrophage activation, the role of non-coding RNAs (ncRNAs), particularly long non-coding RNAs (lncRNAs), is an emerging area of research. Previous work has shown that some lncRNAs, like HOTAIR, are involved in inflammatory processes. However, there's a need to systematically discover and characterize novel lncRNAs that are crucial players in human inflammation and macrophage activation, as their specific roles and regulatory mechanisms are largely unknown.
Methods
The researchers employed a multi-pronged approach:
- Cell Culture and Differentiation: Human acute leukemia THP1 cells were differentiated into macrophages (THP1-MΦ) using phorbol 12-myristate 13-acetate (PMA).
- Inflammatory Stimulation: Differentiated macrophages were stimulated with lipopolysaccharide (LPS), a common bacterial component that triggers inflammation.
- RNA-Sequencing (RNA-seq): Whole transcriptome RNA-seq was performed on LPS-stimulated and control macrophages to identify differentially expressed genes, including lncRNAs.
- RT-qPCR: Quantitative real-time PCR was used to validate the expression levels of identified lncRNAs and known inflammatory markers.
- Western Blotting: Protein levels of key inflammatory mediators and signaling molecules (e.g., NF-κB pathway components) were assessed.
- NF-κB Inhibition Assay: An IKKβ inhibitor (SC-514) was used to block NF-κB signaling and assess its impact on LinfRNA and cytokine expression.
- Antisense Oligonucleotide (ASO)-mediated Knockdown: Specific ASOs were designed to silence the expression of hLinfRNA1 to investigate its functional role in inflammation.
- Immunofluorescence Microscopy: Used to confirm macrophage differentiation by detecting the CD68 marker.
Datasets
The primary dataset generated and analyzed in this study is the whole transcriptome RNA-seq data from LPS-stimulated and control THP1-derived macrophages. This data is available in the Gene Expression Omnibus (GEO) database under accession number GSE224561.
Key Insights and Ideas
- Discovery of Novel Inflammatory lncRNAs (LinfRNAs): The study successfully identified a new class of lncRNAs, termed LinfRNAs, that are significantly induced by LPS stimulation in macrophages. This expands the known repertoire of regulatory molecules involved in inflammation.
- LinfRNAs Mimic Cytokine Expression Patterns: The expression kinetics of many identified LinfRNAs (hLinfRNAs) closely resemble those of well-established pro-inflammatory cytokines (like IL-6 and IL-1β) in response to LPS, suggesting a coordinated regulatory role.
- NF-κB Regulation of LinfRNAs: A significant finding is that the expression of most identified hLinfRNAs is suppressed by inhibiting the NF-κB pathway. This strongly implicates NF-κB as a key upstream regulator of these novel inflammatory lncRNAs.
- Functional Role of hLinfRNA1: The knockdown of hLinfRNA1 demonstrated a direct functional impact, leading to the downregulation of LPS-induced pro-inflammatory cytokines (IL-6, TNFα, IL-1β). This provides concrete evidence that at least one LinfRNA is not just a marker but an active participant in regulating the inflammatory response.
- Potential Link to Disease: The identification of these LinfRNAs in the context of inflammation and macrophage activation opens avenues for exploring their involvement in inflammatory and metabolic diseases.
Key Results
- LPS stimulation of THP1-derived macrophages led to the significant upregulation of several novel lncRNAs, which were collectively named Long-noncoding Inflammation Associated RNAs (LinfRNAs).
- Dose and time-dependent experiments showed that hLinfRNA expression patterns often mirrored those of cytokines like IL-6 and IL-1β.
- Inhibition of NF-κB signaling (using SC-514) significantly suppressed the LPS-induced expression of most hLinfRNAs, indicating NF-κB-dependent regulation.
- Antisense-mediated knockdown of hLinfRNA1 effectively reduced the LPS-induced expression of IL-6, IL-1β, and TNFα by over 50%.
- The study identified specific hLinfRNAs (e.g., ADORA2A-AS1, AC007362.3, AP001610.5, RP11-519G16.3, RP1-68D18.4) that were significantly upregulated upon LPS treatment.
Limitations and Future Work
- Elusive Functions: The paper acknowledges that the detailed structures and functions of most discovered LinfRNAs remain elusive. While hLinfRNA1's role in cytokine regulation is shown, the specific mechanisms for other LinfRNAs are unknown.
- NF-κB Regulation Variability: While most LinfRNAs are regulated by NF-κB, hLinfRNA3's expression was unaffected by NF-κB inhibition, suggesting alternative regulatory pathways for some LinfRNAs.
- In Vitro Model: The study uses the THP1 cell line, which is a widely used model but may not fully recapitulate the complexity of primary human macrophages in vivo.
- Future Directions: The authors suggest that future work should focus on elucidating the precise structural and functional characteristics of these novel hLinfRNAs. Further research is needed to understand their specific modes of regulation, their interactions with proteins and other nucleic acids, and their precise roles in various inflammatory and immune signaling pathways. Investigating their potential as biomarkers or therapeutic targets for inflammatory and metabolic diseases is also a key future goal.
Summary updated